Valion BioVBIO
13F holders, Q3 2025 (September 30)7holders +3
3new positions
0sold out
$2.89avg. 13F price*
At the end of Q3 2025, 7 institutions reported holding Valion Bio Inc. (VBIO) in their 13F filings, up 3 from Q2 2025. 3 opened new positions and 0 sold out. The largest holders were Lasry Marc ($294K), DRW Securities, LLC ($156K) and Marex Group Ltd ($111K).
- Company
- Valion Bio Inc.
- Filed as
- TIVIC HEALTH SYSTEMS INC (Q3 2025)
- CUSIP
- 888705308
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $454K |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 157,003 shares bought and 5,743 shares sold, net +151,260 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Lasry Marc | 1.95% | New | 101,638 | $294K |
| DRW Securities, LLC | 0.01% | New | 53,935 | $156K |
| Marex Group Ltd | 0.00% | Reduce -2.3% | 38,393 | $111K |
| Citigroup Inc. | 0.00% | New | 1,430 | $4K |
| UBS Group AG | 0.00% | Reduce -85.8% | 801 | $2K |
| SBI Securities Co., Ltd. | 0.00% | No change | 16 | $46 |
| Bank of America Corp. | 0.00% | Reduce -11.1% | 8 | $23 |
"% of holder's portfolio" is VBIO's weight in each manager's 13F, not the share of Valion Bio Inc. the manager owns.